Φορτώνει......
Safety and efficacy of treatment with lumacaftor in combination with ivacaftor in younger patients with cystic fibrosis
INTRODUCTION: Cystic fibrosis (CF) is the most common autosomal recessive disorder affecting approximately 70,000 people worldwide. The lack of functional cystic fibrosis transmembrane conductance regulator (CFTR) causes dysregulation of epithelial fluid transport in the lungs, gastrointestinal trac...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Expert Rev Respir Med |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6482058/ https://ncbi.nlm.nih.gov/pubmed/30929526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17476348.2019.1602040 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|